Every stored oracle finding for this trial, including pending, dismissed, rejected, superseded, and accepted items.
NO_DECISIONDismissed100% confidenceGrok 4.20 (xAI)
Will the results be positive?
No public readout available as of April 2026. Trial active not recruiting, primary completion estimated Feb 2026, data expected H1 2026 per Larvol. Sanofi lists as deprioritized Phase 2 in Jan 2026 pipeline, but no specific results framing positive or negative found.
Found Apr 6, 2026, 2:58 PMReviewed Apr 6, 2026, 3:00 PM
NO_DECISIONDismissed90% confidenceGrok 4.20 (xAI)
Will the results be positive?
No public readout available. Trial is active/not recruiting with primary completion in early 2026; no efficacy results, positive/negative framing, or data posted.
Found Apr 6, 2026, 2:09 PMReviewed Apr 6, 2026, 2:19 PM
NO_DECISIONDismissed90% confidencemanual-chat-review
Will the results be positive?
ClinicalTrials.gov still lists this study as active not recruiting with no posted results, so there is not yet a clear public positive or negative trial readout.
Found Apr 4, 2026, 8:54 PMReviewed Apr 4, 2026, 10:32 PM
NO_DECISIONDismissed96% confidenceGPT-5.4 (OpenAI)
Will the results be positive?
No trial-specific public efficacy readout was found. The sponsor study page still describes NCT05588843 as an ongoing Phase 2 study, and FDAAA TrialTracker lists it as ongoing with no actual reporting date/results yet. Without a public readout, positivity cannot be classified.
Found Apr 3, 2026, 4:06 PMReviewed Apr 3, 2026, 4:47 PM
NO_DECISIONDismissed93% confidenceGPT-5.4 (OpenAI)
Will the results be positive?
No trial-specific public efficacy readout was found. Sanofi/Denali still described NCT05588843 as ongoing with results expected in 1H 2026, and a 2026 UC pipeline review said no results were yet available for this exact study. That is insufficient to call the readout positive or negative.
Found Apr 1, 2026, 7:09 PMReviewed Apr 1, 2026, 7:16 PM